Skip to main content
. 2023 Jul 18;59(7):1323. doi: 10.3390/medicina59071323

Table 3.

Outcome data.

Variables All Patients (n = 92)
Technical success 82 (89.1%)
Clinical success 78 (84.8%)
Proximal embolization 19 (20.7%)
Vascular access site hemostasis
  • -

    Manual compression

  • -

    Vascular closure device
86 (93.5%)
6 (6.5%)
Units of packed red blood cells transfused per patient 1 (±0.6)
30-day rebleeding 14 (15.2%)
Non-target embolization 1 (1.1%)
Complications 10 (10.9%)
Vascular access site complications (VASCs) 2 (2.2%)
Complications, according to SIR classifications
  • -

    None

  • -

    Minor (grade 1–2)

  • -

    Major (grade 3–4–5)
82 (89.1%)
8 (8.7%)
2 (2.2%)
Complications, according to CIRSE classification
  • -

    Grade 0

  • -

    Grade 2

  • -

    Grade 3

  • -

    Grade 4
82 (89.1%)
4 (4.3%)
4 (4.3%)
2 (2.2%)
Treatment required for complications
  • -

    None

  • -

    Medical

  • -

    Interventional

  • -

    Surgical
82 (89.1%)
6 (6.5%)
4 (4.4%)
0 (0%)
30-day bleeding-related mortality 5 (5.4%)